-
Je něco špatně v tomto záznamu ?
Garcinol in gastrointestinal cancer prevention: recent advances and future prospects
N. Patwa, R. Chauhan, A. Chauhan, M. Kumar, S. Ramniwas, DM. Mathkor, AK. Saini, HS. Tuli, S. Haque, P. Slama
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2024
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2003-04-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
Public Health Database (ProQuest)
od 1997-01-01 do Před 1 rokem
ROAD: Directory of Open Access Scholarly Resources
od 1997
Springer Journals Complete - Open Access
od 2024-01-01
Springer Nature OA/Free Journals
od 2024-01-01
- MeSH
- fytogenní protinádorové látky terapeutické užití farmakologie MeSH
- gastrointestinální nádory * prevence a kontrola farmakoterapie MeSH
- lidé MeSH
- terpeny * terapeutické užití farmakologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Gastrointestinal cancers continue to pose a significant global health challenge, with millions of new cases diagnosed each year. Despite advancements in treatment, the prognosis for many patients remains poor. This article explores the potential of garcinol, a polyisoprenylated benzophenone found in various Garcinia species, as a therapeutic agent against gastrointestinal malignancies. The objective is to review recent research on garcinol's anticancer properties, its mechanisms of action, and safety aspects. Garcinol exhibits anticancer effects in esophageal, gastric, colorectal, pancreatic, and liver cancers by inhibiting metastasis, inducing apoptosis, and targeting key molecular pathways in cancer progression. Nanotechnology is explored as a means to enhance garcinol delivery and efficacy. Safety assessments suggest a promising toxicity profile. Garcinol shows significant potential as a natural therapeutic agent for gastrointestinal cancers, and future research is needed on optimizing its delivery, exploring synergistic combinations, and conducting clinical trials to validate its efficacy and safety for clinical applications.
Amity Institute of Environmental Toxicology Safety and Management Amity University Noida U P India
Department of Biotechnology Graphic Era Deemed to be University Dehradun Uttarakhand 248002 India
Department of Chemistry Indian Institute of Technology Delhi India
Department of Chemistry Maharishi Markandeshwar University Sadopur Ambala 134007 Haryana India
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019674
- 003
- CZ-PrNML
- 005
- 20241024110711.0
- 007
- ta
- 008
- 241015s2024 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00432-024-05880-6 $2 doi
- 035 __
- $a (PubMed)39066940
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Patwa, Nitika $u Department of Chemistry, Indian Institute of Technology, Delhi, India
- 245 10
- $a Garcinol in gastrointestinal cancer prevention: recent advances and future prospects / $c N. Patwa, R. Chauhan, A. Chauhan, M. Kumar, S. Ramniwas, DM. Mathkor, AK. Saini, HS. Tuli, S. Haque, P. Slama
- 520 9_
- $a Gastrointestinal cancers continue to pose a significant global health challenge, with millions of new cases diagnosed each year. Despite advancements in treatment, the prognosis for many patients remains poor. This article explores the potential of garcinol, a polyisoprenylated benzophenone found in various Garcinia species, as a therapeutic agent against gastrointestinal malignancies. The objective is to review recent research on garcinol's anticancer properties, its mechanisms of action, and safety aspects. Garcinol exhibits anticancer effects in esophageal, gastric, colorectal, pancreatic, and liver cancers by inhibiting metastasis, inducing apoptosis, and targeting key molecular pathways in cancer progression. Nanotechnology is explored as a means to enhance garcinol delivery and efficacy. Safety assessments suggest a promising toxicity profile. Garcinol shows significant potential as a natural therapeutic agent for gastrointestinal cancers, and future research is needed on optimizing its delivery, exploring synergistic combinations, and conducting clinical trials to validate its efficacy and safety for clinical applications.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a gastrointestinální nádory $x prevence a kontrola $x farmakoterapie $7 D005770
- 650 12
- $a terpeny $x terapeutické užití $x farmakologie $7 D013729
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a fytogenní protinádorové látky $x terapeutické užití $x farmakologie $7 D000972
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Chauhan, Ritu $u Department of Biotechnology, Graphic Era Deemed to be University, Dehradun, Uttarakhand, 248002, India
- 700 1_
- $a Chauhan, Abhishek $u Amity Institute of Environmental Toxicology Safety and Management, Amity University, Noida, U.P, India
- 700 1_
- $a Kumar, Manoj $u Department of Chemistry, Maharishi Markandeshwar University, Sadopur-Ambala, 134007, Haryana, India
- 700 1_
- $a Ramniwas, Seema $u University Centre for Research and Development, University Institute of Pharmaceutical Sciences, Chandigarh University, Gharuan, Mohali, 140413, India
- 700 1_
- $a Mathkor, Darin Mansor $u Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan, 45142, Saudi Arabia
- 700 1_
- $a Saini, Adesh Kumar $u Department of Bio-Sciences and Technology, Maharishi Markandeshwar Engineering College, Maharishi Markandeshwar (Deemed to Be University), 133207, Mullana, Ambala, India
- 700 1_
- $a Tuli, Hardeep Singh $u Department of Bio-Sciences and Technology, Maharishi Markandeshwar Engineering College, Maharishi Markandeshwar (Deemed to Be University), 133207, Mullana, Ambala, India
- 700 1_
- $a Haque, Shafiul $u Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 11022801, Lebanon. shafiul.haque@hotmail.com
- 700 1_
- $a Slama, Petr $u Laboratory of Animal Immunology and Biotechnology, Department of Animal Morphology, Physiology and Genetics, Faculty of AgriSciences, Mendel University in Brno, 61300, Brno, Czech Republic. petr.slama@mendelu.cz
- 773 0_
- $w MED00009972 $t Journal of cancer research and clinical oncology $x 1432-1335 $g Roč. 150, č. 7 (2024), s. 370
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39066940 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024110705 $b ABA008
- 999 __
- $a ok $b bmc $g 2202108 $s 1231647
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 150 $c 7 $d 370 $e 20240727 $i 1432-1335 $m Journal of cancer research and clinical oncology $n J Cancer Res Clin Oncol $x MED00009972
- LZP __
- $a Pubmed-20241015